FDA Inspection 788580 — Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC

Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC — FEI 1222181

The FDA completed an inspection of Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC on June 20, 2012 in Andover, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 20, 2012
Fiscal Year
2012
Product Type
Devices
Project Area
Compliance: Devices
Location
Andover, MA (United States)